Interleukin‐17A educated hepatic stellate cells promote hepatocellular carcinoma occurrence through fibroblast activation protein expression

Author:

Ni Jun‐Sheng1,Fu Si‐Yuan1,Wang Zong‐Yan1,Ding Wen‐Bin1,Huang Jian1,Guo Xing‐Gang1,Gu Fang‐Ming1

Affiliation:

1. The Third Department of Hepatic Surgery Third Affiliated Hospital of Naval Medical University Shanghai China

Abstract

AbstractBackgroundLiver cancer is typified by a complex inflammatory tumor microenvironment, where an array of cytokines and stromal cells orchestrate a milieu that significantly influences tumorigenesis. Interleukin‐17A (IL‐17A), a pivotal pro‐inflammatory cytokine predominantly secreted by Th17 cells, is known to play a substantial role in the etiology and progression of liver cancer. However, the precise mechanism by which IL‐17A engages with hepatic stellate cells (HSCs) to facilitate the development of hepatocellular carcinoma (HCC) remains to be fully elucidated. This investigation seeks to unravel the interplay between IL‐17A and HSCs in the context of HCC.MethodsAn HCC model was established in male Sprague–Dawley rats using diethylnitrosamine to explore the roles of IL‐17A and HSCs in HCC pathogenesis. In vivo overexpression of Il17a was achieved using adeno‐associated virus. A suite of molecular techniques, including RT‐qPCR, enzyme‐linked immunosorbent assays, Western blotting, cell counting kit‐8 assays and colony formation assays, was employed for in vitro analyses.ResultsThe study findings indicate that IL‐17A is a key mediator in HCC promotion, primarily through the activation of hepatic progenitor cells (HPCs). This pro‐tumorigenic influence appears to be mediated by HSCs, rather than through a direct effect on HPCs. Notably, IL‐17A‐induced expression of fibroblast activation protein (FAP) in HSCs emerged as a critical factor in HCC progression. Silencing Fap in IL‐17A‐stimulated HSCs was observed to reverse the HCC‐promoting effects of HSCs.ConclusionsThe collective evidence from this study implicates the IL‐17A/FAP signaling axis within HSCs as a contributor to HCC development by enhancing HPC activation. These findings bolster the potential of IL‐17A as a diagnostic and preventative target for HCC, offering new avenues for therapeutic intervention.

Funder

National Natural Science Foundation of China

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3